The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Barnhill Gregory Hurd since 2007.
The trader's CIK number is 1273979.
At the time of the last reporting, Barnhill Gregory Hurd was the Director of Pure Bioscience, Inc.. (stock ticker symbol PURE).
Also see all insider trading activities at Pure Bioscience, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | OSIR | 50,000 | $356,675 | 0 | $0 | 0 | $0 |
| 2007 | OSIR | 0 | $0 | 0 | $0 | 2,500 | $59,050 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | PURE | 75,000 | $61,100 | 0 | $0 | 100,000 | $109,000 |
| 2010 | PURE | 30,000 | $60,960 | 142,002 | $204,270 | 0 | $0 |
| 2009 | PURE | 25,000 | $42,645 | 59,667 | $86,067 | 300,000 | $159,000 |
| 2008 | PURE | 113,130 | $456,500 | 0 | $0 | 0 | $0 |
1. Osiris Therapeutics, Inc. (OSIR)
2. Pure Bioscience, Inc. (PURE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-06-03 | OSIR | Buy | 25,000 | 7.20 | 179,975 |
| 2011-06-06 | OSIR | Buy | 25,000 | 7.07 | 176,700 |
| 2007-02-05 | OSIR | Option Ex | 2,500 | 23.62 | 59,050 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-06-29 | PURE | Buy | 50,000 | .78 | 38,750 |
| 2011-06-21 | PURE | Buy | 25,000 | .89 | 22,350 |
| 2011-03-09 | PURE | Option Ex | 50,000 | 1.65 | 82,500 |
| 2011-01-03 | PURE | Option Ex | 50,000 | .53 | 26,500 |
| 2010-07-07 | PURE | Buy | 5,000 | 1.84 | 9,200 |
| 2010-04-14 | PURE | Buy | 5,000 | 2.72 | 13,600 |
| 2010-04-06 | PURE | Buy | 10,000 | 2.02 | 20,160 |
| 2010-03-15 | PURE | Buy | 10,000 | 1.80 | 18,000 |
| 2010-01-27 | PURE | Sale | 28,492 | 1.35 | 38,521 |
| 2010-01-26 | PURE | Sale | 40,000 | 1.36 | 54,560 |
| 2010-01-19 | PURE | Sale | 3,500 | 1.50 | 5,250 |
| 2010-01-20 | PURE | Sale | 29,410 | 1.44 | 42,409 |
| 2010-01-21 | PURE | Sale | 27,090 | 1.55 | 41,881 |
| 2010-01-14 | PURE | Sale | 1,110 | 1.57 | 1,742 |
| 2010-01-15 | PURE | Sale | 700 | 1.55 | 1,082 |
| 2010-01-13 | PURE | Sale | 11,700 | 1.61 | 18,825 |
| 2009-12-24 | PURE | Sale | 1,000 | 1.39 | 1,390 |
| 2009-12-22 | PURE | Sale | 21,924 | 1.43 | 31,395 |
| 2009-12-23 | PURE | Sale | 1,500 | 1.43 | 2,145 |
| 2009-12-21 | PURE | Sale | 35,243 | 1.45 | 51,137 |
| 2009-12-14 | PURE | Option Ex | 150,000 | .53 | 79,500 |
| 2009-07-21 | PURE | Buy | 10,000 | 1.67 | 16,700 |
| 2009-04-23 | PURE | Buy | 5,000 | 1.69 | 8,450 |
| 2009-04-07 | PURE | Buy | 5,000 | 1.75 | 8,745 |
| 2009-03-20 | PURE | Buy | 5,000 | 1.75 | 8,750 |
| 2009-01-27 | PURE | Option Ex | 150,000 | .53 | 79,500 |
| 2008-12-29 | PURE | Buy | 10,000 | 3.02 | 30,200 |
| 2008-10-24 | PURE | Buy | 3,300 | 2.70 | 8,910 |
| 2008-10-23 | PURE | Buy | 10,000 | 2.95 | 29,500 |
| 2008-10-22 | PURE | Buy | 10,000 | 2.95 | 29,500 |
| 2008-10-17 | PURE | Buy | 10,000 | 3.00 | 30,019 |
| 2008-10-17 | PURE | Buy | 10,000 | 3.00 | 30,019 |
| 2008-07-02 | PURE | Buy | 9,830 | 3.87 | 38,042 |
| 2008-06-26 | PURE | Buy | 10,000 | 4.18 | 41,800 |
| 2008-04-21 | PURE | Buy | 10,000 | 4.70 | 47,000 |
| 2008-04-07 | PURE | Buy | 10,000 | 5.72 | 57,170 |
| 2008-04-07 | PURE | Buy | 10,000 | 5.72 | 57,170 |
| 2008-04-07 | PURE | Buy | 10,000 | 5.72 | 57,170 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barnhill Gregory Hurd (Director of Pure Bioscience, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.